Status:

COMPLETED

Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19

Lead Sponsor:

Memorial Sloan Kettering Cancer Center

Conditions:

Covid19

Coronavirus

Eligibility:

All Genders

18+ years

Phase:

PHASE1

Brief Summary

The purpose of the study is to evaluate the safety and tolerability of a 30-week aerobic exercise therapy program in cancer patients recovering from COVID-19. The study will look at whether the aerobi...

Eligibility Criteria

Inclusion

  • Age ≥ 18
  • Previously admitted to a hospital for Covid-19
  • Discharged from hospital for at least 30 days
  • Previously treated for cancer at MSK
  • Interval of ≥ 12 months but ≤ 10 years following completion of primary non-hormonal anti-cancer therapy (current endocrine therapy and maintenance therapy allowed)
  • Space to house a treadmill at personal residence
  • Cleared for exercise participation as per screening clearance via the Physical Activity Readiness Questionnaire (PAR-Q+)
  • Performing less than 90 minutes of structured moderate-intensity or strenuous-intensity exercise per week, as evaluation by self-report
  • If a female of child-bearing potential, must not be pregnant or planning to become pregnant during the study.
  • Women \<50 years old who are of child-bearing potential must have a negative pregnancy test within 14 days of enrollment.

Exclusion

  • Currently receiving home oxygen after discharge
  • Enrollment onto any other interventional investigational study
  • Current treatment for any other diagnosis of invasive cancer of any kind
  • Distant metastatic malignancy of any kind
  • Receiving non-hormonal anticancer therapy
  • Any other condition or intercurrent illness that, in the opinion of the investigator, makes the subject a poor candidate for study participation

Key Trial Info

Start Date :

March 29 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 24 2025

Estimated Enrollment :

3 Patients enrolled

Trial Details

Trial ID

NCT04824443

Start Date

March 29 2021

End Date

October 24 2025

Last Update

October 27 2025

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)

Basking Ridge, New Jersey, United States, 07920

2

Memorial Sloan Kettering Monmouth (Limited protocol activities)

Middletown, New Jersey, United States, 07748

3

Memorial Sloan Kettering Bergen (Limited Protocol Activities)

Montvale, New Jersey, United States, 07645

4

Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities)

Commack, New York, United States, 11725